In July 2024, AEVR hosted a highly successful Congressional Briefing on Dry Eye Disease, drawing a substantial turnout of attendees and featuring powerful presentations from leading experts in the field. This event underscored the critical need for increased funding in vision science research to address the widespread impact of dry eye disease on millions of Americans.
Record Attendance and Engaging Presentations
Held on Capitol Hill, the briefing attracted a diverse audience, including congressional staff, researchers, clinicians, and advocates. The attendees were deeply engaged by the informative and compelling presentations, which highlighted the latest advancements in dry eye disease research and the urgent need for continued investment.
Highlighting the Prevalence and Impact of Dry Eye Disease
Dry eye disease affects an estimated 16 million Americans, causing significant discomfort and impairing daily activities. It is a multifactorial condition that can lead to chronic pain, visual disturbances, and decreased quality of life. The prevalence of dry eye disease increases with age, making it a growing concern as the population continues to age.
Quotes from Key Speakers
AEVR’s Executive Director, Dan Ignaszewski, emphasized the importance of advocacy and funding for vision research. “The success of this briefing demonstrates the critical need for continued investment in vision science. Dry eye disease is a pervasive condition that affects millions, and it’s essential that we support research to develop better treatments and improve patients’ quality of life,” said Ignaszewski.
Rebecca Petris, Founder of the Dry Eye Foundation, also provided a poignant perspective on the personal impact of the disease. “Dry eye disease is more than just a minor inconvenience; it’s a serious condition that can profoundly affect every aspect of a person’s life. We need to raise awareness and advocate for the necessary funding to support research and find effective treatments,” Petris remarked.
Dr. Alan Kabat, a leading optometrist and dry eye expert, highlighted the scientific advancements being made. “Research in dry eye disease has made significant strides, but there’s still a long way to go. Continued funding is crucial to developing new therapies and improving patient outcomes,” said Kabat.
Molly Chidsey, a patient advocate, shared her personal experience with the condition. “Living with dry eye disease has been incredibly challenging. It’s crucial that we continue to support research that can lead to better treatments and provide hope for patients like me,” Chidsey stated.
The Importance of Funding Vision Science Research
The briefing highlighted the significant progress that has been made in understanding dry eye disease, but also the critical gaps that remain. Funding for vision science research is essential to develop innovative treatments, improve diagnostic methods, and ultimately find a cure. Increased investment in this area will not only benefit those suffering from dry eye disease but also contribute to broader advancements in eye health and vision care.
Moving Forward
AEVR remains committed to advocating for robust funding for vision research and ensuring that dry eye disease and other vision-related conditions receive the attention they deserve. The success of this Congressional Briefing is a testament to the power of collaboration and the importance of continued advocacy. Together, we can make a difference in the lives of those affected by dry eye disease and continue to advance the field of vision science.
If you missed the briefing, you can tune in by following this link.
